VIVIMEDLABBSEVivimed Labs LtdLowNeutral
Announced Tue, 7 Oct · 17:11 IST

Revised AGM Proceedings

VIVIMEDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vivimed Labs held its 37th Annual General Meeting on September 30, 2025, via video conferencing from 3:00 PM to 3:45 PM, with 41 members participating. The company has now submitted a revised copy of the AGM proceedings to BSE, citing a printer/technical issue as the reason for the delayed filing. Eight resolutions were tabled, including adoption of FY25 audited financial statements, re-appointment of directors (Mr. Manohar Rao Varalwar, Mr. Santosh Varalwar, and Mr. Sandeep Varalwar), appointment of Secretarial Auditors, ratification of Cost Auditors' remuneration, and a proposal to issue securities worth up to Rs. 500 Crore. Remote e-voting was open from September 27 to September 29, 2025, with voting results to be announced separately.

Likely market impact

The delayed filing is a minor compliance lapse but unlikely to materially affect shareholders. The Rs. 500 Crore securities issuance proposal is the key item to watch, as it could lead to equity dilution once shareholder approval and pricing details are confirmed.